中国组织工程研究 ›› 2016, Vol. 20 ›› Issue (1): 31-35.doi: 10.3969/j.issn.2095-4344.2016.01.006

• 脐带脐血干细胞 umbilical cord blood stem cells • 上一篇    下一篇

脐带间充质干细胞在颅脑损伤模型鼠体内的迁徙与定位

刘红林,刘志军,陈小兵,胡文忠,丁丙谦   

  1. 河南大学淮河医院神经外科,河南省开封市 475000
  • 收稿日期:2015-11-18 出版日期:2016-01-01 发布日期:2016-01-01
  • 作者简介:刘红林,男,1972年生,江苏省丰县人,汉族,2007年郑州大学毕业,硕士,副主任医师,主要从事显微神经外科方面的研究。

Migration and localization of umbilical cord mesenchymal stem cells implanted into brain injury model rats

Liu Hong-lin, Liu Zhi-jun, Chen Xiao-bing, Hu Wen-zhong, Ding Bing-qian   

  1. Department of Neurosurgery, Huaihe Hospital of Henan University, Kaifeng 475000, Henan Province, China
  • Received:2015-11-18 Online:2016-01-01 Published:2016-01-01
  • About author:Liu Hong-lin, Master, Associate chief physician, Department of Neurosurgery, Huaihe Hospital of Henan University, Kaifeng 475000, Henan Province, China

摘要:

文章快速阅读:

文题释义:

脐带间充质干细胞:具有较高的分化潜能,可向多个方向进行分化,在骨、软骨、肌肉、肌腱、韧带、神经、肝、内皮和心肌等组织工程方面具有广阔的临床应用前景。从人脐带中分离出间充质干细胞,细胞含量、增殖能力优于骨髓间充质干细胞,免疫原性比骨髓间充质干细胞低,并且具有取材方便,无伦理学争议等优点。

BrdU标记法:是近年来出现的一种新型的标记方法,当细胞处于DNA合成期而同时又有 BrdU存在时,BrdU会掺入新合成的DNA中,随后通过抗BrdU单克隆抗体进行免疫细胞化学染色进行示踪。与同位素和荧光标记技术相比较,BrdU标记和检测的方法简便,准确性及标记率高,是反映细胞增殖及跟踪监测移植细胞的理想指标,但 BrdU标记细胞如果发生凋亡或死亡,其释放的BrdU则可掺入到处于细胞循环S期的任何细胞,从而难以区分移植细胞和宿主细胞。 

 

背景:选择有效的手段,标记和追踪细胞在体内的分布、分化及转归,才能深入探讨细胞发挥治疗效果的具体机制。

目的:了解BrdU标记脐带间充质干细胞在颅脑损伤大鼠体内的迁徙和定位情况。
方法:分离培养人脐带间充质干细胞并进行细胞表面标志物鉴定,取第3代人脐带间充质干细胞采用BrdU进行标记,MTT法检测细胞增殖能力。将BrdU标记的人脐带间充质干细胞经尾静脉注射到颅脑损伤模型大鼠体内,移植后14 d取损伤处脑组织制备组织切片,倒置荧光显微镜下观察人脐带间充质干细胞的迁徙和定位情况。

结果与结论:经流式细胞仪检测,细胞表达CD29、CD44、CD105,不表达造血细胞表面特异性标志CD34和CD45。通过生长曲线可以发现,细胞在接种1-3 d处于调整期,第3-5天进入对数生长期。移植后14 d在脑损伤部位可以观察到BrdU染色阳性细胞,表明移植的人脐带间充质干细胞在大鼠体内发生迁徙,经过大鼠的外周血液循环迁徙达到颅脑损伤部位,实现对损伤部位的有效修复。 

 ORCID: 0000-0003-4229-7570(刘红林)

关键词: 干细胞, 脐血干细胞, 脐带间充质干细胞, 颅脑损伤, 干细胞标记示踪技术, 细胞迁徙, 细胞定位

Abstract:

BACKGROUND: Choosing an effective means to label and trace the distribution, differentiation and migration of cells in vivo help to further explore the specific mechanism of cells that exert a therapeutic effect.
OBJECTIVE: To understand the migration and localization of BrdU-labeled human umbilical cord mesenchymal stem cells in brain injury model rats.
METHODS: Human umbilical cord blood samples were obtained, and the isolation of human umbilical cord mesenchymal stem cells was carried out. The primary and passage culture were performed. The phenotype of cells was detected by flow cytometry. Passage 3 human umbilical cord mesenchymal stem cells were labeled using BrdU, and the cell proliferation was detected using MTT method. BrdU-labeled cells were injected into brain injury rats via the tail vein. At 14 days after transplantation, brain tissues in the injury region were cut into sections and the migration and location of the umbilical cord mesenchymal stem cells were observed under inverted fluorescence microscope.
RESULTS AND CONCLUSION: Cell surface specific markers CD45 and CD34 were detected by flow cytometry, but the cells could not express CD44, CD105 and CD29. Based on the cell growth curve, the cells came into a conditioning period at 1-3 days of seeding and came into a logarithmic phase at 3-5 days. BrdU-positive cells were visible at the injury region after 14 days, indicating that in the rats, transplanted human umbilical cord mesenchymal stem cells migrated from the peripheral blood to the site of brain injury to achieve the effective repair of injured parts. 

中图分类号: